Patrick Brossard
Impact in
-
- Multiple Sclerosis Research Studies
-
- Sphingolipid Metabolism and Signaling
Papers in
-
- Sphingolipid Metabolism and Signaling 10
-
- Pharmacogenetics and Drug Metabolism 2
- Co-authors
- Jasper Dingemanse (12 shared papers)Haidar Maatouk (2 shared papers)Atef Halabi (2 shared papers)Daniele D’Ambrosio (5 shared papers)Matthias Hoch (7 shared papers)Hartmut Derendorf (1 shared paper)Jian Xu (1 shared paper)Andreas Krause (2 shared papers)
- Journals
- The Journal of Clinical Pharmacology (2 papers)Clinical Therapeutics (2 papers)Regulatory Toxicology and Pharmacology (1 paper)European Journal of Pharmaceutical Sciences (1 paper)Xenobiotica (1 paper)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Patrick Brossard
17 papers receiving 359 citations
Peers
Comparison fields: 5 of 41
- Pathology and Forensic Medicine 83
- Molecular Biology 208
- Pediatrics, Perinatology and Child Health 36
- Pharmacology 25
- Physiology 63
Countries citing papers authored by Patrick Brossard
This map shows the geographic impact of Patrick Brossard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Brossard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Brossard more than expected).
Fields of papers citing papers by Patrick Brossard
This network shows the impact of papers produced by Patrick Brossard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Brossard. The network helps show where Patrick Brossard may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Brossard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 99 | |
| 2 | 2014 | 60 | |
| 3 | 2017 | 42 | |
| 4 | 2014 | 26 | |
| 5 | 2014 | 21 | |
| 6 | 2014 | 21 | |
| 7 | 2015 | 19 | |
| 8 | 2014 | 18 | |
| 9 | 2014 | 17 | |
| 10 | 2017 | 17 | |
| 11 | 2013 | 16 | |
| 12 | 2014 | 11 | |
| 13 | 2017 | 9 | |
| 14 | 2018 | 7 | |
| 15 | 2013 | 1 | |
| 16 | 2013 | 1 | |
| 17 | 2024 | 1 | |
| 18 | 2025 | 1 |
About Patrick Brossard
Patrick Brossard is a scholar working on Molecular Biology, Pharmacology, Physiology, Hematology and Cardiology and Cardiovascular Medicine, having authored 18 papers that have together received 387 indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (10 papers), Smoking Behavior and Cessation (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Autoimmune and Inflammatory Disorders Research (2 papers), Cardiac electrophysiology and arrhythmias (2 papers), Veterinary Pharmacology and Anesthesia (1 paper), Reproductive Health and Contraception (1 paper) and Pharmaceutical studies and practices (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (83 citations), Molecular Biology (208 citations), Pediatrics, Perinatology and Child Health (36 citations), Pharmacology (25 citations) and Physiology (63 citations). Patrick Brossard has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Jasper Dingemanse, Haidar Maatouk, Atef Halabi, Daniele D’Ambrosio, Matthias Hoch, Hartmut Derendorf, Jian Xu, Andreas Krause, Michael W. Scherz and Frank Lüdicke. Their work appears in journals such as The Journal of Clinical Pharmacology, Clinical Therapeutics, Regulatory Toxicology and Pharmacology, European Journal of Pharmaceutical Sciences and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.